139 related articles for article (PubMed ID: 9865279)
1. Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantation.
Kaden J; Strobelt V; May G
Transplant Proc; 1998 Dec; 30(8):4011-4. PubMed ID: 9865279
[No Abstract] [Full Text] [Related]
2. Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation.
Kaden J; May G; Strobelt V; Groth J; Müller P
Transplant Proc; 1997; 29(1-2):344-7. PubMed ID: 9123032
[No Abstract] [Full Text] [Related]
3. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
[No Abstract] [Full Text] [Related]
4. Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.
Kaden J; May G; Müller P; Groth J; Strobelt V; Eger E; Wohlfahrt L
Transplant Proc; 1995 Feb; 27(1):1060-1. PubMed ID: 7878804
[No Abstract] [Full Text] [Related]
5. Perioperative administration of single, high-dose of ATG-Fresenius-S as an induction immunosuppressive therapy in cadaveric renal transplantation: preliminary results.
Samsel R; Rowiński W; Chmura A; Włodarczyk Z; Wyzgał J; Cieciura T; Łagiewska B; Pliszczyński J; Korczak G; Paczek L; Wałaszewski J; Lao M
Transplant Proc; 2001 Sep; 33(6):2952-4. PubMed ID: 11543807
[No Abstract] [Full Text] [Related]
6. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
[No Abstract] [Full Text] [Related]
7. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
[TBL] [Abstract][Full Text] [Related]
8. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR
Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516
[No Abstract] [Full Text] [Related]
9. Chagas disease and transplantation.
Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
[No Abstract] [Full Text] [Related]
10. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
Siu CW; Chan TM; Li FK; Choy BY; Lui SL; Lo CY; Tang S; Lo WK; Lai KN
Transplant Proc; 2000 Nov; 32(7):1932-4. PubMed ID: 11120007
[No Abstract] [Full Text] [Related]
11. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
[No Abstract] [Full Text] [Related]
12. Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation?
Mozes MF; Venkat KK; Kupin W; Dumler F; Gracida C; Uniewski M; Anaise D; Tang DH
Transplant Proc; 1993 Feb; 25(1 Pt 1):575-6. PubMed ID: 8438420
[No Abstract] [Full Text] [Related]
13. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
14. Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients.
Varghese Z; Abudher MN; Fernando ON; Moorhead JF
Transplant Proc; 2001 May; 33(3):2251-3. PubMed ID: 11377518
[No Abstract] [Full Text] [Related]
15. Donor-specific transfusion in living-related renal transplants.
Basri N; Nezamuddin N; Aman H; Banqash H; Sharwani N
Transplant Proc; 1992 Oct; 24(5):1746. PubMed ID: 1412822
[No Abstract] [Full Text] [Related]
16. Preoperative ATG bolus treatment increase CsA sensitivity of peripheral blood lymphocytes (PBLS) in renal transplant patients.
Abudher MN; Moorhead JF; Fernando ON; Varghese Z
Transplant Proc; 1999 Dec; 31(8):3361-4. PubMed ID: 10616507
[No Abstract] [Full Text] [Related]
17. Single-bolus high-dose ATG for prophylaxis of rejection in renal transplantation--a prospective, randomized study.
Yussim A; Shapira Z
Transpl Int; 2000; 13 Suppl 1():S293-4. PubMed ID: 11112016
[TBL] [Abstract][Full Text] [Related]
18. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
Shiroki R; Hoshinaga K; Tsukiashi Y; Higuchi T; Izumitani M; Horiba M; Naide Y
Transplant Proc; 1997 Dec; 29(8):3571-3. PubMed ID: 9414841
[No Abstract] [Full Text] [Related]
19. Kidney transplantation in pediatric population.
Mota C; Henriques C; Sarmento M; Pereira E; Xavier E; Pereira M
Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
[No Abstract] [Full Text] [Related]
20. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
